RESEARCH LITERACY / SOURCE NOTES
Do peptides work? Read the evidence by compound
There is no single answer for “peptides”. A finding about one molecule, product or route cannot establish that a different peptide works. Ask what was tested, in whom, and against which outcome.
Editorial draft · primary sources linked; not independently clinically reviewed.
Editorial update:
| Evidence | Useful for | Does not establish |
|---|---|---|
| Cell or animal experiment | Mechanisms and hypotheses | A human treatment benefit |
| Human controlled trial | A defined comparison and outcome | Every route, population or product |
| Product label | Approved product-specific use | Approval of all materials with that name |
| Community report | Questions and lived observations | Causality or a safe schedule |
Start with a testable claim
“Works” needs an outcome: a laboratory signal, a symptom, a change in a scan or a clinical event are different endpoints. Write down the exact compound, formulation and claimed benefit before searching. Keep the question narrow enough that a study could answer it.
Our practical reading order is identity → population and route → comparator → measured outcome → adverse effects → remaining uncertainty. This is an editorial reading framework, not a validated effectiveness score.
Compare unlike evidence carefully
The EGRIFTA WR label describes a specific tesamorelin product for excess abdominal fat in adults with HIV-associated lipodystrophy. That is not a general claim about peptide use. A 2023 retatrutide trial studied adults with obesity; a clinical trial is not itself marketing authorisation.
- DailyMed — EGRIFTA WR US prescribing information ↗Specific US product and indication; not a global approval statement.
- Jastreboff et al., 2023 — retatrutide phase 2 obesity trial ↗Randomised phase 2 trial; abstract reviewed, not a prescribing label.
Keep the route attached to the result
A small GHK-Cu skin-care study after laser resurfacing did not show a significant difference in objective skin assessments, although satisfaction differed. It does not answer whether injections affect hair, recovery or ageing.
User observations can suggest questions. Without a comparison group, they cannot separate a compound’s effects from concurrent changes, natural recovery or expectation. Record unwanted effects as carefully as perceived benefits.
- Miller et al., 2006 — topical GHK-Cu after CO₂ laser resurfacing ↗Small human topical study; abstract reviewed, not an injectable study.
- NIH — clinical research basics ↗Research design and participant context.
Use the original record
Follow the source, not a screenshot of a headline. Check the publication type, who completed the study, whether the endpoint was planned and what the authors say about limitations. A mechanistic explanation can be plausible while a clinical benefit remains unproven.
Continue with the linked profiles for separate human, preclinical and safety sections. Draft status stays visible so a clear layout is not mistaken for a completed clinical review.